UOC
CC icon

UBS O'Connor’s Chemours CC Stock Holding History

UBS O'Connor’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$619K Hold
46,900
– – 0.02% 180
2025
Q3 		$396K Hold
46,900
– – 0.01% 212
2025
Q2 		$638K Hold
46,900
– – 0.02% 261
2025
Q1 		$546K Hold
46,900
– – 0.01% 219
2024
Q4 		$443K Hold
46,900
– – 0.01% 293
2024
Q3 		$352K Hold
46,900
– – 0.01% 363
2024
Q2 		$279K Buy
+46,900
New +$1.23M 0.01% 402

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

UBS O'Connor's CC Position: Q4 2023 in Review

UBS O'Connor sold out of Chemours (CC) in Q4 2023, closing a stake of 39,671 shares — an estimated $1.11M sold.

UBS O'Connor first reported a position in CC in Q3 2017 and held it in 13 quarters. The position peaked at $17.7M in Q1 2021. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

  • UBS O'Connor reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 39,671 Chemours shares in Q4 2023, an estimated $1.11M.
  • UBS O'Connor first reported a position in Chemours in Q3 2017 and held it in 13 quarters.
  • UBS O'Connor's Chemours position peaked at $17.7M in Q1 2021.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.